Research Articles | Page 3 | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.

Research Articles

  1. Home
  2. Research

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
Survival and quality of life in patients with lower risk myelodysplastic syndromes exposed to erythropoiesis-stimulating agents: an observational cohort study Feb 2025 Lancet Haematology Myelodysplastic Syndromes (MDS)
Genome sequencing in the management of myelodysplastic syndromes and related disorders Feb 2025 Haematologica Myelodysplastic Syndromes (MDS)
Diagnosis of myelodysplastic syndromes: the classic and the novel Feb 2025 Haematologica Myelodysplastic Syndromes (MDS)
Treatment of high-risk myelodysplastic syndromes Feb 2025 Haematologica Myelodysplastic Syndromes (MDS)
Current landscape of paroxysmal nocturnal hemoglobinuria in the era of complement inhibitors and regulators Dec 2024 Therapeutic Advances in Hematology Paroxysmal Nocturnal Hemoglobinuria (PNH)
Pegcetacoplan: the first and only C3-targeted therapy for the treatment of adults with paroxysmal nocturnal hemoglobinuria Dec 2024 Expert Review of Hematology Paroxysmal Nocturnal Hemoglobinuria (PNH)
Real-World Study of the Burden of Myelodysplastic Syndromes in Patients and Their Caregivers in Europe and the United States Dec 2024 Oncology and Therapy Myelodysplastic Syndromes (MDS)
Efficacy and Safety of Venetoclax Plus Azacitidine for Patients With Treatment-Naive High-Risk Myelodysplastic Syndromes Dec 2024 Blood Myelodysplastic Syndromes (MDS)
RNA splicing as a therapeutic target in myelodysplastic syndromes Dec 2024 Seminars in Hematology Myelodysplastic Syndromes (MDS)
Crovalimab in the paroxysmal nocturnal hemoglobinuria treatment landscape Dec 2024 Immunotherapy Paroxysmal Nocturnal Hemoglobinuria (PNH)